ACADIA Pharmaceuticals Inc.
ACAD
$21.72
-$0.08-0.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.67% | 281.13% | 169.18% | 40.44% | -86.79% |
| Total Depreciation and Amortization | 2.36% | -0.88% | 0.51% | -0.54% | -43.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.96% | -2,064.85% | -5.67% | 38.21% | 106.67% |
| Change in Net Operating Assets | 115.02% | -602.20% | -158.09% | 298.10% | -135.90% |
| Cash from Operations | 169.73% | -165.60% | 16.15% | 214.70% | -49.67% |
| Capital Expenditure | -30.14% | -932.22% | -30.64% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 237.85% | 34.32% | -83.65% | 65.34% | -418.77% |
| Cash from Investing | 218.64% | 29.59% | -83.29% | 65.10% | -201.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.33% | 140.54% | -40.94% | 768.12% | -6.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -81.33% | 140.54% | -40.94% | 768.12% | -6.65% |
| Foreign Exchange rate Adjustments | 257.14% | -- | -100.00% | 580.00% | 91.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 227.57% | -1,979.49% | -88.10% | 135.96% | -161.96% |